Opened Office News Today

Phase 2b ALS topline results expected December 2023 CAMBRIDGE, Mass., Oct. 17, 2023 /PRNewswire/ -- NeuroSense Therapeutics Ltd. , a company developing treatments for severe neurodegenerative...

“My concern is to get to the bottom of what happened here, but also … where’s this happening in other parts of this country?”

“My concern is to get to the bottom of what happened here, but also … where’s this happening in other parts of this country?”